相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease
Roland C. Zahn et al.
BLOOD (2010)
The unraveling panoply of Francisella tularensis virulence attributes
Karin L. Meibom et al.
CURRENT OPINION IN MICROBIOLOGY (2010)
Predictive models and correlates of protection for testing biodefence vaccines
E. Diane Williamson et al.
EXPERT REVIEW OF VACCINES (2010)
A Francisella tularensis Live Vaccine Strain (LVS) Mutant with a Deletion in capB, Encoding a Putative Capsular Biosynthesis Protein, Is Significantly More Attenuated than LVS yet Induces Potent Protective Immunity in Mice against F. tularensis Challenge
Qingmei Jia et al.
INFECTION AND IMMUNITY (2010)
Lung CD4-CD8- Double-Negative T Cells Are Prominent Producers of IL-17A and IFN-γ during Primary Respiratory Murine Infection with Francisella tularensis Live Vaccine Strain
Siobhan C. Cowley et al.
JOURNAL OF IMMUNOLOGY (2010)
Characterization of lethal inhalational infection with Francisella tularensis in the common marmoset (Callithrix jacchus)
Michelle Nelson et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Immunoproteomics Analysis of the Murine Antibody Response to Vaccination with an Improved Francisella tularensis Live Vaccine Strain (LVS)
Susan M. Twine et al.
PLOS ONE (2010)
Identification, Characterization and Immunogenicity of an O-Antigen Capsular Polysaccharide of Francisella tularensis
Michael A. Apicella et al.
PLOS ONE (2010)
Molecular Immune Responses to Aerosol Challenge with Francisella tularensis in Mice Inoculated with Live Vaccine Candidates of Varying Efficacy
Hua Shen et al.
PLOS ONE (2010)
Detoxified Endotoxin Vaccine (J5dLPS/OMP) Protects Mice Against Lethal Respiratory Challenge with Francisella tularensis SchuS4
Stephen H. Gregory et al.
VACCINE (2010)
Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs
Rebecca V. Anderson et al.
VACCINE (2010)
Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: Effects of host background and route of immunization
J. Wayne Conlan et al.
VACCINE (2010)
Concordant Proficiency in Measurement of T-Cell Immunity in Human Immunodeficiency Virus Vaccine Clinical Trials by Peripheral Blood Mononuclear Cell and Enzyme-Linked Immunospot Assays in Laboratories from Three Continents
Mark J. Boaz et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Oral Live Vaccine Strain-Induced Protective Immunity against Pulmonary Francisella tularensis Challenge Is Mediated by CD4+ T Cells and Antibodies, Including Immunoglobulin A
Heather J. Ray et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Development of monoclonal antibodies for analyzing immune and hematopoietic systems of common marmoset
Yoshie Kametani et al.
EXPERIMENTAL HEMATOLOGY (2009)
Identification of an Essential Francisella tularensis subsp tularensis Virulence Factor
Aiping Qin et al.
INFECTION AND IMMUNITY (2009)
T Cells from Lungs and Livers of Francisella tularensis-Immune Mice Control the Growth of Intracellular Bacteria
Carmen M. Collazo et al.
INFECTION AND IMMUNITY (2009)
Establishment of lethal inhalational infection with Francisella tularensis (tularaemia) in the common marmoset (Callithrix jacchus)
Michelle Nelson et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
Differential Requirements for Protection against Mucosal Challenge with Francisella tularensis in the Presence versus Absence of Cholera Toxin B and Inactivated F. tularensis
Constantine Bitsaktsis et al.
JOURNAL OF IMMUNOLOGY (2009)
CD4 downregulation by memory CD4+ T cells in vivo renders African green monkeys resistant to progressive SIVagm infection
Coreen M. Beaumier et al.
NATURE MEDICINE (2009)
Differential susceptibility of Sprague-Dawley and Fischer 344 rats to infection by Francisella tularensis
Claudine R. Raymond et al.
MICROBIAL PATHOGENESIS (2009)
Identification of Genes Contributing to the Virulence of Francisella tularensis SCHU S4 in a Mouse Intradermal Infection Model
Konstantin Kadzhaev et al.
PLOS ONE (2009)
Generation of heterogeneous memory T cells by live attenuated tularemia vaccine in humans
Rosangela Salerno-Goncalves et al.
VACCINE (2009)
Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis
Shite Sebastian et al.
VACCINE (2009)
Vaccination with a defined Francisella tularensis subsp novicida pathogenicity island mutant (ΔiglB) induces protective immunity against homotypic and heterotypic challenge
Yu Cong et al.
VACCINE (2009)
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans
H. M. El Sahly et al.
VACCINE (2009)
Development pathway for biodefense vaccines
Alan D. T. Barrett et al.
VACCINE (2009)
Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis
Qingmei Jia et al.
VACCINE (2009)
Vaccination of Fischer 344 rats against pulmonary infections by Francisella tularensis type A strains
Terry H. Wu et al.
VACCINE (2009)
Pathology of Inhalational Francisella tularensis spp. tularensis SCHU S4 Infection in African Green Monkeys (Chlorocebus aethiops)
N. A. Twenhafel et al.
VETERINARY PATHOLOGY (2009)
Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis
Girish S. Kirimanjeswara et al.
IMMUNOLOGICAL REVIEWS (2008)
Native outer membrane proteins protect mice against pulmonary challenge with virulent type a Francisella tularensis
Jason F. Huntley et al.
INFECTION AND IMMUNITY (2008)
Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis
Deepak B. Rawool et al.
JOURNAL OF IMMUNOLOGY (2008)
The membrane form of tumor necrosis factor is sufficient to mediate partial innate immunity to Francisella tularensis live vaccine strain
Siobhan C. Cowley et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis
J. Wayne Conlan et al.
MOLECULAR IMMUNOLOGY (2008)
Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS)
J. E. Eyles et al.
MICROBIAL PATHOGENESIS (2008)
A Francisella tularensis Schu S4 Purine Auxotroph Is Highly Attenuated in Mice but Offers Limited Protection against Homologous Intranasal Challenge
Roger D. Pechous et al.
PLOS ONE (2008)
An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain
Chandra Shekhar Bakshi et al.
VACCINE (2008)
An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes
Marcela F. Pasetti et al.
VACCINE (2008)
The FDA animal efficacy rule and biodefense
Gigi Kwik Gronvalli et al.
NATURE BIOTECHNOLOGY (2007)
SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection
Constantinos Petrovas et al.
BLOOD (2007)
Immunodominant Francisella tularensis antigens identified using proteome microarray. Crown Copyright 2007 Dstl
Jim E. Eyles et al.
PROTEOMICS (2007)
Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis
Rhonda KuoLee et al.
VACCINE (2007)
Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination
Claudette L. Fuller et al.
MOLECULAR IMMUNOLOGY (2007)
Active suppression of the pulmonary immune response by Francisella tularensis Schu4
Catharine M. Bosio et al.
JOURNAL OF IMMUNOLOGY (2007)
A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice
J. E. Quarry et al.
VACCINE (2007)
Identification of immunoreactive antigens in membrane proteins enriched fraction from Francisella tularensis LVS
Sylva Janovska et al.
IMMUNOLOGY LETTERS (2007)
The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens
Rebecca M. Thomas et al.
INFECTION AND IMMUNITY (2007)
Multiple vaccine and pyridostigmine bromide interactions in the common marmoset Callithrix jacchus:: Immunological and endocrinological effects
Rebecca J. Hornby et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Immunoproteomic analysis of the murine antibody response to successful and failed immunization with live anti-Francisella vaccines
Susan M. Twine et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Transcriptional profiling of host responses in mouse lungs following aerosol infection with type A Francisella tularensis
H Andersson et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Low dose aerosol infection of mice with virulent type A Francisella tularensis induces severe thymus atrophy and CD4+CD8+ thymocyte depletion
WX Chen et al.
MICROBIAL PATHOGENESIS (2005)
Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A
TH Wu et al.
INFECTION AND IMMUNITY (2005)
Proteomic analysis of anti-Franciselia tularensis LVS antibody response in murine model of tularemia
J Havlasová et al.
PROTEOMICS (2005)
Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease
M Green et al.
VACCINE (2005)
Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an αβ T cell- and interferon gamma-dependent mechanism
JW Conlan et al.
VACCINE (2005)
Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis
WX Chen et al.
MICROBIAL PATHOGENESIS (2004)
Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F-tularensis
H Shen et al.
MICROBIAL PATHOGENESIS (2004)
Preventive vaccines against bioterrorism: evaluation of efficacy and safety
AD Horne et al.
VACCINE (2004)
Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen
H Shen et al.
VACCINE (2004)
Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis
WX Chen et al.
MICROBIAL PATHOGENESIS (2004)
Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensis subsp tularensis
JL Prior et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2003)
Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen:: protection varies depending on pathogen virulence, route of exposure, and host genetic background
WX Chen et al.
VACCINE (2003)
Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon γ receptors
SC Cowley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis:: bacteriologic and histopathologic studies
JW Conlan et al.
MICROBIAL PATHOGENESIS (2003)
Francisella novicida LPS has greater immunobiological activity in mice than F-tularensis LPS, and contributes to F-novicida murine pathogenesis
TL Kieffer et al.
MICROBES AND INFECTION (2003)
Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen
JW Conlan et al.
VACCINE (2002)
Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis
M Fulop et al.
VACCINE (2001)
Tularemia as a biological weapon - Medical and public health management
DT Dennis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
